drugset
drugset / Trial / NCT02585908

Safety and Efficacy of γδ T Cell Against Gastric Cancer

NCT02585908 ↗

Phase 1/2 Unknown 120 enrolled Beijing Doing Biomedical Co., Ltd.
RandomizedParallel-groupSingle-blindTreatment

Summary

In this study, safety and effects of γδT cells on human gastric cancer are going to be investigated.

Timeline

Start
2019-12
Primary completion
2021-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject CIK Cell therapy — —
Subject γδ T Cell therapy — —

Indications

gastric cancer